Beta-Carotene

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity skin heart

Research Overview

Research on β-carotene has most heavily focused on its role as a dietary carotenoid with antioxidant properties and as a provitamin A compound, with major study areas including eye health (particularly age-related macular degeneration [AMD] in the context of AREDS/AREDS2 formulations), cancer and cardiovascular disease prevention in generally healthy adults, and mechanistic work related to oxidative stress and immune modulation. Dietary sources (e.g., carrots, sweet potatoes, tomatoes) and absorption/metabolism have also been widely reviewed, and β-carotene is frequently discussed alongside other carotenoids (notably lutein/zeaxanthin and lycopene). In addition, β-carotene appears in research on complex supplements/foods such as Spirulina, where it is considered one of several bioactive constituents potentially contributing to antioxidant and immunomodulatory effects, although attribution to β-carotene specifically is often uncertain.

The strongest evidence supports a clear distinction between β-carotene obtained from foods versus β-carotene as a supplement used for disease prevention. Large supplementation-focused evidence syntheses and long-term follow-up data indicate harms outweigh benefits for β-carotene supplementation for prevention of cardiovascular disease or cancer in the general adult population, with an increased lung cancer risk observed in randomized trial settings and persisting in long-term follow-up (e.g., AREDS2 cohort follow-up). For AMD, evidence from AREDS2 supports replacing β-carotene with lutein/zeaxanthin: lutein/zeaxanthin shows a modest beneficial association with reduced progression to late AMD, while β-carotene confers no comparable advantage and carries lung cancer risk. Overall, the most defensible conclusions are that β-carotene is an important dietary carotenoid/provitamin A, but β-carotene supplementation for chronic disease prevention lacks net benefit and may cause harm in some populations.

Key gaps include clarifying dose-response relationships and population-specific risks (e.g., by smoking history and baseline nutritional status), differentiating effects of β-carotene within whole-food matrices versus isolated supplements, and determining whether any subgroups benefit from supplementation without incurring unacceptable risk. More mechanistic and clinical research is also needed to disentangle β-carotene’s specific contribution from co-occurring carotenoids and other bioactives (e.g., in Spirulina) and to explain why antioxidant hypotheses have not translated consistently into clinical benefit in large trials. Finally, while carotenoids broadly are being investigated for cognitive, cardiometabolic, and cancer-related outcomes, β-carotene-specific clinical evidence remains mixed, supporting the need for well-designed studies that prioritize clinically meaningful endpoints and careful harm assessment.

1. What conditions has Beta-Carotene been studied for?

  • Age-related macular degeneration (AMD) progression (as part of the original AREDS formulation and compared with lutein/zeaxanthin in AREDS2 follow-up).

  • Lung cancer risk (notably as an adverse outcome signal in AREDS2 long-term follow-up among those assigned beta-carotene).

  • Cardiovascular disease (CVD) prevention (evaluated in population-level supplementation evidence summarized by USPSTF and meta-analyses).

  • Cancer prevention (overall) (USPSTF evidence review; meta-analyses including beta-carotene).

  • Antioxidant/oxidative stress and immune-related outcomes (indirectly, including in Spirulina trials/reviews where beta-carotene is cited as an important molecule contributing to antioxidant and immunomodulatory effects).

  • Vitamin A deficiency-related physiology (beta-carotene as a provitamin A carotenoid; discussed mechanistically in carotenoid reviews).

2. Does it work in treating those conditions? Summarize the evidence.

  • AMD: In the AREDS2 10-year follow-up, lutein/zeaxanthin was favored over beta-carotene. A direct comparison showed a lower hazard of progression to late AMD with lutein/zeaxanthin vs beta-carotene (HR 0.85; 95% CI, 0.73–0.98; P=0.02). The study concluded lutein/zeaxanthin was an appropriate replacement for beta-carotene in AREDS-type supplements.

    Interpretation: These data do not support beta-carotene as the preferred carotenoid for AMD progression in this context; lutein/zeaxanthin appears at least as effective and potentially better.

  • CVD prevention: The USPSTF concluded with moderate certainty that beta-carotene supplementation has harms that outweigh benefits for prevention of CVD or cancer, and recommends against its use for these prevention purposes (D recommendation). Separately, meta-analyses summarized in the provided abstract reported no effect of beta-carotene on cardiovascular disease outcomes.

    Interpretation: Evidence does not support beta-carotene supplements for preventing CVD in generally well-nourished adults.

  • Cancer prevention: USPSTF recommends against beta-carotene supplementation for prevention of cancer (D recommendation), indicating harms outweigh benefits. The meta-analysis summary also reports no preventive benefit for beta-carotene.

    Interpretation: Evidence does not support beta-carotene supplements for cancer prevention in the general adult population.

  • Oxidative stress / immune outcomes: The Spirulina review describes clinical trials where Spirulina reduced exercise-induced skeletal muscle damage and modulated immune markers; it notes beta-carotene as an “important molecule” among contributors. However, this is not direct evidence that isolated beta-carotene supplementation produces these effects.

    Interpretation: Evidence in the abstracts is indirect and does not establish beta-carotene alone as an effective treatment for oxidative stress or immune conditions.

3. What health benefits does it have?

  • Provitamin A activity: Beta-carotene functions as a vitamin A precursor (noted in the carotenoid overview), supporting vitamin A-related physiology (e.g., vision and immune function), particularly relevant when dietary vitamin A is insufficient.

  • Antioxidant-related functions (mechanistic/associative): Carotenoids broadly “primarily exert antioxidant effects,” and reviews link beta-carotene (often alongside other carotenoids like lycopene) with antioxidant defense and associations with lower risk of some chronic diseases. However, the abstracts also emphasize that large supplementation studies have produced mixed results.

  • Dietary pattern marker: Because beta-carotene is abundant in fruits and vegetables (e.g., carrots, sweet potatoes), higher intake from foods may correlate with healthier dietary patterns; the abstracts discuss potential benefits across eye health, cardiovascular health, cognition, and cancer prevention for carotenoids as a class, but do not establish beta-carotene supplements as reliably beneficial.

4. Does it have any downsides or side effects?

  • Increased lung cancer risk (supplement form): In the AREDS2 10-year follow-up, assignment to beta-carotene was associated with higher odds of lung cancer (OR 1.82; 95% CI, 1.06–3.12; P=0.02). The authors concluded beta-carotene “nearly doubled” lung cancer risk, whereas lutein/zeaxanthin did not show a statistically significant increase.

  • Net harm for prevention use: USPSTF concludes (moderate certainty) that harms of beta-carotene supplementation outweigh benefits for prevention of CVD or cancer and recommends against its use for these purposes.

  • Mixed/uncertain benefit in large supplementation trials: The carotenoid overview notes mixed results in large population-based supplementation studies for some carotenoids, underscoring uncertainty and the possibility that supplementation does not replicate benefits associated with dietary intake.

  • Other adverse effects not detailed in the provided abstracts: The abstracts provided do not enumerate common minor side effects (e.g., carotenodermia) or specific drug interactions; conclusions here are therefore limited to the harms explicitly reported (notably lung cancer risk in the AREDS2 context and USPSTF net-harm determination).

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings (i.e., differential benefits/harms of beta-carotene by genotype). Therefore, no evidence-based conclusions about specific genetic variants can be made from these sources.

Practical implication based on the abstracts: because harms (notably lung cancer risk in AREDS2 follow-up and USPSTF’s D recommendation for prevention) are documented at the population level, any potential genotype-specific benefit would require dedicated studies that are not described here.

References

  1. Carotenoids in human nutrition and health.
    Manfred Eggersdorfer, Adrian Wyss (2018) - Archives of biochemistry and biophysics
  2. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview.
    Qinghua Wu, Lian Liu, Anca Miron, Blanka Klímová, Dan Wan, Kamil Kuča (2016) - Archives of toxicology
  3. Nutritional Benefits of Lycopene and Beta-Carotene: A Comprehensive Overview.
    Tabussam Tufail, Huma Bader Ul Ain, Sana Noreen, Ali Ikram, Muhammad Tayyab Arshad, Muhammed Adem Abdullahi (2024) - Food science & nutrition
  4. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Emily Y Chew, Traci E Clemons, Elvira Agrón, Amitha Domalpally, Tiarnán D L Keenan, Susan Vitale, Claire Weber, Douglas C Smith, William Christen (2022) - JAMA ophthalmology
  5. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
    Carol M Mangione, Michael J Barry, Wanda K Nicholson, Michael Cabana, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Chyke A Doubeni, Carlos Roberto Jaén, Martha Kubik, Li Li, Gbenga Ogedegbe, Lori Pbert, John M Ruiz, James Stevermer, John B Wong (2022) - JAMA
  6. Scientific opinion on the tolerable upper intake level for preformed vitamin A and β-carotene.
    Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, Stefaan de Henauw, Karen-Ildico Hirsch-Ernst, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Georg Lietz, Giovanni Passeri, Ionut Craciun, Lucia Fabiani, Zsuzsanna Horvath, Silvia Valtueña Martínez, Androniki Naska (2024) - EFSA journal. European Food Safety Authority
  7. Challenges in Functional Food Products with the Incorporation of Some Microalgae.
    Abuzer Çelekli, Buket Özbal, Hüseyin Bozkurt (2024) - Foods (Basel, Switzerland)
  8. Pharmaceutical and nutraceutical potential of natural bioactive pigment: astaxanthin.
    Apurva D Patil, Pramod J Kasabe, Padma B Dandge (2022) - Natural products and bioprospecting
  9. Supplemental Vitamins and Minerals for CVD Prevention and Treatment.
    David J A Jenkins, J David Spence, Edward L Giovannucci, Young-In Kim, Robert Josse, Reinhold Vieth, Sonia Blanco Mejia, Effie Viguiliouk, Stephanie Nishi, Sandhya Sahye-Pudaruth, Melanie Paquette, Darshna Patel, Sandy Mitchell, Meaghan Kavanagh, Tom Tsirakis, Lina Bachiri, Atherai Maran, Narmada Umatheva, Taylor McKay, Gelaine Trinidad, Daniel Bernstein, Awad Chowdhury, Julieta Correa-Betanzo, Gabriella Del Principe, Anisa Hajizadeh, Rohit Jayaraman, Amy Jenkins, Wendy Jenkins, Ruben Kalaichandran, Geithayini Kirupaharan, Preveena Manisekaran, Tina Qutta, Ramsha Shahid, Alexis Silver, Cleo Villegas, Jessica White, Cyril W C Kendall, Sathish C Pichika, John L Sievenpiper (2018) - Journal of the American College of Cardiology
  10. Sunscreen and prevention of skin aging: a randomized trial.
    Maria Celia B Hughes, Gail M Williams, Peter Baker, Adèle C Green (2013) - Annals of internal medicine
  11. The Effect of Beta-Carotene on Cognitive Function: A Systematic Review.
    Diana Marisol Abrego-Guandique, Maria Luisa Bonet, Maria Cristina Caroleo, Roberto Cannataro, Paola Tucci, Joan Ribot, Erika Cione (2023) - Brain sciences
  12. Non-Provitamin A and Provitamin A Carotenoids as Immunomodulators: Recommended Dietary Allowance, Therapeutic Index, or Personalized Nutrition?
    Elisabetta Toti, C-Y Oliver Chen, Maura Palmery, Débora Villaño Valencia, Ilaria Peluso (2018) - Oxidative medicine and cellular longevity
  13. Pharmacological values and therapeutic properties of black tea (Camellia sinensis): A comprehensive overview.
    Muhammad Naveed, Jannat BiBi, Asghar Ali Kamboh, Imran Suheryani, Ihsanullah Kakar, Sarfaraz Ali Fazlani, Xia FangFang, Shahmir Ali Kalhoro, Liang Yunjuan, Mohib Ullah Kakar, Mohamed E Abd El-Hack, Ahmed E Noreldin, Shi Zhixiang, Chen LiXia, Zhou XiaoHui (2018) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  14. Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases.
    Hock Eng Khoo, Hui Suan Ng, Wai-Sum Yap, Henri Ji Hang Goh, Hip Seng Yim (2019) - Antioxidants (Basel, Switzerland)
  15. NUTRITIONAL AND TOXICOLOGICAL ASPECTS OF SPIRULINA (ARTHROSPIRA).
    Gabriela Gutiérrez-Salmeán, Luis Fabila-Castillo, German Chamorro-Cevallos (2015) - Nutricion hospitalaria
  16. The role of carotenoids in bone health-A narrative review.
    Bartosz Kulczyński, Andrzej Sidor, Anna Brzozowska, Anna Gramza-Michałowska (2024) - Nutrition (Burbank, Los Angeles County, Calif.)
  17. The Extraction of β-Carotene from Microalgae for Testing Their Health Benefits.
    Jing Wang, Xinge Hu, Junbin Chen, Tiannan Wang, Xianju Huang, Guoxun Chen (2022) - Foods (Basel, Switzerland)
  18. Gut microbiota regulation and anti-inflammatory effect of β-carotene in dextran sulfate sodium-stimulated ulcerative colitis in rats.
    Lingyu Zhu, Yang Song, Huilin Liu, Min Wu, Haizhou Gong, Hainan Lan, Xin Zheng (2021) - Journal of food science
  19. Nutritional supplements and cancer: potential benefits and proven harms.
    Michelle Harvie (2014) - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
  20. Beta-carotene and its protective effect on gastric cancer.
    Qian-Hui Chen, Bao-Kang Wu, Dan Pan, Li-Xuan Sang, Bing Chang (2021) - World journal of clinical cases


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!